SS.MNS-(D2Mit6-D2Rat303)/Ayd |
receptor-dependent blood vessel maximum contractile force to receptor-independent blood vessel maximum contractile force ratio |
Kreb's solution perfusate then phenylephrine (1-100 mmol/l) and NG-nitroarginine methyl ester (100 umol/l) |
Dutil J, et al., Physiol Genomics 2005 Mar 1;. |
vasoconstriction trait |
male |
98 days
| 13 |
143.03 |
% |
6.62 |
23.87 |
tissue force analysis utilizing a force transducer |
0.0 |
0 |
isometric force transducer |
|
69057 |
1096 |
SS.MNS-(D2Mit6-D2Rat303)/Ayd |
blood vessel contractile force measurement |
Kreb's solution perfusate then potassium chloride solution (40 mmol/l) and NG-nitroarginine methyl ester (100 umol/l) |
Dutil J, et al., Physiol Genomics 2005 Mar 1;. |
vasoconstriction trait |
male |
98 days
| 13 |
1.6 |
g |
0.12 |
0.43 |
tissue force analysis utilizing a force transducer |
0.0 |
0 |
isometric force transducer |
|
69051 |
1096 |
SS.MNS-(D2Mit6-D2Rat303)/Ayd |
receptor-dependent blood vessel maximum contractile force to receptor-independent blood vessel maximum contractile force ratio |
Kreb's solution perfusate then phenylephrine (1-100 mmol/l) |
Dutil J, et al., Physiol Genomics 2005 Mar 1;. |
vasoconstriction trait |
male |
98 days
| 13 |
100.16 |
% |
5.63 |
20.3 |
tissue force analysis utilizing a force transducer |
0.0 |
0 |
isometric force transducer |
|
69053 |
1096 |
SS.MNS-(D2Mit6-D2Rat303)/Ayd |
receptor-dependent blood vessel maximum contractile force to receptor-independent blood vessel maximum contractile force ratio |
Kreb's solution perfusate then angiotensin II (0.3-300 umol/l) and NG-nitroarginine methyl ester (100 umol/l) |
Dutil J, et al., Physiol Genomics 2005 Mar 1;. |
vasoconstriction trait |
male |
98 days
| 13 |
26.63 |
% |
4.0 |
14.42 |
tissue force analysis utilizing a force transducer |
0.0 |
0 |
isometric force transducer |
|
69070 |
1096 |
SS.MNS-(D2Mit6-D2Rat303)/Ayd |
receptor-dependent blood vessel maximum contractile force to receptor-independent blood vessel maximum contractile force ratio |
Kreb's solution perfusate then angiotensin II (0.3-300 umol/l) |
Dutil J, et al., Physiol Genomics 2005 Mar 1;. |
vasoconstriction trait |
male |
98 days
| 13 |
19.33 |
% |
3.67 |
13.23 |
tissue force analysis utilizing a force transducer |
0.0 |
0 |
isometric force transducer |
|
69066 |
1096 |
SS.MNS-(D2Mit6-D2Rat303)/Ayd |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
Kreb's solution perfusate then phenylephrine (1-100 mmol/l) and NG-nitroarginine methyl ester (100 umol/l) |
Dutil J, et al., Physiol Genomics 2005 Mar 1;. |
vasoconstriction trait |
male |
98 days
| 13 |
-7.41 |
null |
0.16 |
0.58 |
tissue force analysis utilizing a force transducer |
0.0 |
0 |
isometric force transducer |
EC50 value is probably moles/liter |
69059 |
1096 |
SS.MNS-(D2Mit6-D2Rat303)/Ayd |
blood vessel contractile force measurement |
Kreb's solution perfusate then potassium chloride solution (40 mmol/l) |
Dutil J, et al., Physiol Genomics 2005 Mar 1;. |
vasoconstriction trait |
male |
98 days
| 13 |
1.62 |
g |
0.09 |
0.32 |
tissue force analysis utilizing a force transducer |
0.0 |
0 |
isometric force transducer |
|
69049 |
1096 |
SS.MNS-(D2Mit6-D2Rat303)/Ayd |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
Kreb's solution perfusate then phenylephrine (1-100 mmol/l) |
Dutil J, et al., Physiol Genomics 2005 Mar 1;. |
vasoconstriction trait |
male |
98 days
| 13 |
-6.96 |
null |
0.17 |
0.61 |
tissue force analysis utilizing a force transducer |
0.0 |
0 |
isometric force transducer |
EC50 value is probably moles/liter |
69055 |
1096 |
SS.MNS-(D2Mit6-D2Rat303)/Ayd |
logarithm of the concentration of angiotensin II at which the force of blood vessel contraction is half the maximum value (Log EC50) |
Kreb's solution perfusate then angiotensin II (0.3-300 umol/l) and NG-nitroarginine methyl ester (100 umol/l) |
Dutil J, et al., Physiol Genomics 2005 Mar 1;. |
vasoconstriction trait |
male |
98 days
| 13 |
-7.2 |
null |
0.31 |
1.12 |
tissue force analysis utilizing a force transducer |
0.0 |
0 |
isometric force transducer |
|
69072 |
1096 |
SS.MNS-(D2Mit6-D2Rat303)/Ayd |
logarithm of the concentration of angiotensin II at which the force of blood vessel contraction is half the maximum value (Log EC50) |
Kreb's solution perfusate then angiotensin II (0.3-300 umol/l) |
Dutil J, et al., Physiol Genomics 2005 Mar 1;. |
vasoconstriction trait |
male |
98 days
| 13 |
-7.86 |
null |
0.27 |
0.97 |
tissue force analysis utilizing a force transducer |
0.0 |
0 |
isometric force transducer |
|
69068 |
1096 |